- Home
- AMWL vs INZY Comparison
AMWL vs INZY Comparison
Compare AMWL & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWL
- INZY
- Stock Information
- Founded
- AMWL 2006
- INZY 2015
- Country
- AMWL United States
- INZY United States
- Employees
- AMWL N/A
- INZY N/A
- Industry
- AMWL Retail: Computer Software & Peripheral Equipment
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- AMWL Technology
- INZY Health Care
- Exchange
- AMWL Nasdaq
- INZY Nasdaq
- Market Cap
- AMWL 142.5M
- INZY 165.1M
- IPO Year
- AMWL 2020
- INZY 2020
- Fundamental
- Price
- AMWL $7.83
- INZY $2.94
- Analyst Decision
- AMWL Hold
- INZY Strong Buy
- Analyst Count
- AMWL 4
- INZY 7
- Target Price
- AMWL $12.50
- INZY $16.14
- AVG Volume (30 Days)
- AMWL 65.0K
- INZY 920.5K
- Earning Date
- AMWL 02-12-2025
- INZY 11-05-2024
- Dividend Yield
- AMWL N/A
- INZY N/A
- EPS Growth
- AMWL N/A
- INZY N/A
- EPS
- AMWL N/A
- INZY N/A
- Revenue
- AMWL $254,035,000.00
- INZY N/A
- Revenue This Year
- AMWL N/A
- INZY N/A
- Revenue Next Year
- AMWL $24.96
- INZY N/A
- P/E Ratio
- AMWL N/A
- INZY N/A
- Revenue Growth
- AMWL N/A
- INZY N/A
- 52 Week Low
- AMWL $5.00
- INZY $2.39
- 52 Week High
- AMWL $31.60
- INZY $7.80
- Technical
- Relative Strength Index (RSI)
- AMWL 36.37
- INZY 39.38
- Support Level
- AMWL $9.20
- INZY $2.65
- Resistance Level
- AMWL $9.41
- INZY $3.28
- Average True Range (ATR)
- AMWL 0.53
- INZY 0.25
- MACD
- AMWL -0.17
- INZY 0.07
- Stochastic Oscillator
- AMWL 7.87
- INZY 39.07
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.